677C TO 677T MUTATION IN THE 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE(MTHFR) GENE AND PLASMA HOMOCYST(E)INE LEVELS IN PATIENTS WITH TIA ORMINOR STROKE

Citation
W. Lalouschek et al., 677C TO 677T MUTATION IN THE 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE(MTHFR) GENE AND PLASMA HOMOCYST(E)INE LEVELS IN PATIENTS WITH TIA ORMINOR STROKE, Journal of the neurological sciences, 155(2), 1998, pp. 156-162
Citations number
25
Categorie Soggetti
Neurosciences
ISSN journal
0022510X
Volume
155
Issue
2
Year of publication
1998
Pages
156 - 162
Database
ISI
SICI code
0022-510X(1998)155:2<156:6T6MIT>2.0.ZU;2-Y
Abstract
It was the aim of this study to determine the associations of clinical and laboratory data with plasma homocyst(e)ine levels in patients wit h transient ischemic attack (TIA) or minor stroke (MS), with special r eference to their 677C to T mutation status in the 5,10-methylenetetra hydrofolate reductase (5,10-MTHFR) gene. Seventy-six patients with TIA or MS were investigated at least 3 months after their (last) clinical event. By means of univariate analysis, significant correlations of h omocyst(e)ine levels with male gender (P<0.02), age (P<0.0005), creati nine levels (P<0.0002), folate levels (inversely, P<0.05), and alcohol use (P<0.02) were found, but not with vitamin B-12 levels. Multivaria te regression analysis, including age, creatinine levels, and folate l evels as independent variables, revealed age (P<0.01) and creatinine l evels (P<0.02) to be significantly correlated with homocyst(e)ine leve ls. After adjustment for age, creatinine levels and homocyst(e)ine lev els remained significantly correlated to each other (P<0.005), whereas the relation between folate levels and homocyst(e)ine levels was no l onger significant (P=0.10). Mutation-positive patients exhibited moder ately and statistically non-significantly higher homocyst(e)ine levels than mutation-negative patients, particularly those who were homozygo us positive. Homocyst(e)ine levels were closely correlated with creati nine levels (P<0.0002) and with folate levels (inversely, P<0.05), but only in mutation-positive and not in mutation-negative patients. Homo zygous positive, heterozygous positive, and mutation-negative patients did not differ with respect to clinical and laboratory data concernin g 'risk factors for stroke' or co-existing vascular disease. In conclu sion, the associations of creatinine levels and, inversely, of folate levels with plasma homocyst(e)ine levels in patients with TIA or MS ar e dependent on the 5,10-MTHFR mutation status. Significant correlation s between these variables were found only in mutation-positive but not in mutation-negative patients. (C) 1998 Elsevier Science B.V.